BR112013032714A2 - curativo para ferida biorreabsorvível - Google Patents
curativo para ferida biorreabsorvívelInfo
- Publication number
- BR112013032714A2 BR112013032714A2 BR112013032714A BR112013032714A BR112013032714A2 BR 112013032714 A2 BR112013032714 A2 BR 112013032714A2 BR 112013032714 A BR112013032714 A BR 112013032714A BR 112013032714 A BR112013032714 A BR 112013032714A BR 112013032714 A2 BR112013032714 A2 BR 112013032714A2
- Authority
- BR
- Brazil
- Prior art keywords
- wound dressing
- tissues
- unbraided
- bioresorbable
- wound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/62—Compostable, hydrosoluble or hydrodegradable materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/04—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres having existing or potential cohesive properties, e.g. natural fibres, prestretched or fibrillated artificial fibres
- D04H1/30—Collagen
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/40—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties
- D04H1/42—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres without existing or potential cohesive properties characterised by the use of certain kinds of fibres insofar as this use has no preponderant influence on the consolidation of the fleece
- D04H1/4266—Natural fibres not provided for in group D04H1/425
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Textile Engineering (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Surgery (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
Abstract
resumo patente de invenção: "curativo para ferida biorreabsorvível". a presente invenção refere-se aos novos tecidos não trançados que contêm proteínas do fator de crescimento e de diferenciação. os ditos tecidos são especificamente projetados para acelerar a regeneração tissular e os processos de cicatrização de feridas de tecidos de mamíferos. além disso, a invenção provê curativos, almofadas ou implantes para feridas que compreendem os novos tecidos não trançados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11170971A EP2537538A1 (en) | 2011-06-22 | 2011-06-22 | Bioresorbable Wound Dressing |
PCT/EP2012/061965 WO2012175611A1 (en) | 2011-06-22 | 2012-06-21 | Bioresorbable wound dressing |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013032714A2 true BR112013032714A2 (pt) | 2017-01-24 |
Family
ID=46354320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013032714A BR112013032714A2 (pt) | 2011-06-22 | 2012-06-21 | curativo para ferida biorreabsorvível |
Country Status (13)
Country | Link |
---|---|
US (3) | US9278156B2 (pt) |
EP (2) | EP2537538A1 (pt) |
JP (1) | JP6138773B2 (pt) |
KR (1) | KR101964482B1 (pt) |
CN (1) | CN103874516B (pt) |
AU (1) | AU2012274046C1 (pt) |
BR (1) | BR112013032714A2 (pt) |
CA (1) | CA2839142C (pt) |
ES (1) | ES2539405T3 (pt) |
RU (1) | RU2577155C2 (pt) |
TW (1) | TWI572336B (pt) |
WO (1) | WO2012175611A1 (pt) |
ZA (1) | ZA201309341B (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9999702B2 (en) * | 2010-04-09 | 2018-06-19 | Kci Licensing Inc. | Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds |
EP2537538A1 (en) | 2011-06-22 | 2012-12-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Bioresorbable Wound Dressing |
WO2014190038A2 (en) | 2013-05-22 | 2014-11-27 | The Penn State Research Foundation | Wound dressings and applications thereof |
AU2017230387B9 (en) * | 2016-03-07 | 2022-08-04 | National Institute For Materials Science | Sustained drug release sheet for treating nerve damage |
FR3058041B1 (fr) * | 2016-10-28 | 2021-06-04 | Centre Hospitalier Regional Univ Lille | Dispositif apte a etre implante dans le corps d'un sujet pour former un implant - masse tissulaire et procede associes. |
CA3062432A1 (en) | 2017-05-07 | 2018-11-15 | Locus Ip Company, Llc | Cosmetic compositions for skin health and methods of using same |
US11771599B2 (en) | 2017-11-03 | 2023-10-03 | Kci Licensing, Inc. | Extended wear-time dressing |
CN108210979B (zh) * | 2018-01-28 | 2020-09-29 | 山东东贝医药科技有限公司 | 一种医用杀菌纤维敷料 |
CN108286132B (zh) * | 2018-03-27 | 2020-06-23 | 界首市圣通无纺布有限公司 | 一种具有抗菌功能的易降解无纺布加工方法 |
WO2019227034A1 (en) * | 2018-05-25 | 2019-11-28 | Locus Ip Company, Llc | Therapeutic compositions for enhanced healing of wounds and scars |
CN108893792B (zh) * | 2018-07-13 | 2020-11-03 | 深圳大学 | 生物活性纤维及其制备方法、应用和制备系统 |
US20200375802A1 (en) * | 2019-06-03 | 2020-12-03 | Convatec Limited | Methods and devices to disrupt and contain pathogens |
US20220409769A1 (en) * | 2019-09-17 | 2022-12-29 | Mayo Foundation For Medical Education And Research | Methods and materials for treating fistulas |
WO2022138206A1 (ja) * | 2020-12-22 | 2022-06-30 | 日本毛織株式会社 | 創傷被覆材 |
WO2022172929A1 (ja) * | 2021-02-09 | 2022-08-18 | 信越化学工業株式会社 | ゼラチン含有デバイス |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ287715B6 (en) | 1992-02-12 | 2001-01-17 | Bioph Biotech Entw Pharm Gmbh | DNA sequence, recombinant DNA molecule containing thereof, process for preparing protein from the group of TGF-beta substances, pharmaceutical preparation containing such protein, antibody or fragment thereof and its use |
DE19525416A1 (de) | 1995-07-12 | 1997-01-16 | Bioph Biotech Entw Pharm Gmbh | Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems |
EP1439190A1 (en) | 1993-01-12 | 2004-07-21 | The Johns Hopkins University School Of Medicine | Growth differentiation factor-5 |
IL110589A0 (en) | 1993-08-10 | 1994-11-11 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF- beta family |
PT733109E (pt) | 1993-12-07 | 2006-07-31 | Genetics Inst Llc | Proteinas morfogeneticas dos 0ss0s pmo-12 e pmo-13 e as suas composicoes para inducao de tendao |
AU1120295A (en) | 1994-11-07 | 1996-05-31 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Cartilage-derived morphogenetic proteins |
JPH08209435A (ja) * | 1995-01-30 | 1996-08-13 | Sangi Co Ltd | 生体適合糸 |
PL186518B1 (pl) | 1995-04-19 | 2004-01-30 | Bioph Biotech Entw Pharm Gmbh | Białko, kompozycja farmaceutyczna i sposób wytwarzania białka |
ATE245996T1 (de) | 1995-06-05 | 2003-08-15 | Inst Genetics Llc | Verwendung von knochenmorphogeneseproteinen zur heilung und reparatur von bindegewebebefestigung |
JPH0931098A (ja) | 1995-07-24 | 1997-02-04 | Hoechst Japan Ltd | 新規なタンパク質hmwヒトmp52 |
ZA966489B (en) | 1995-08-03 | 1997-02-26 | Bioph Biotech Entw Pharm Gmbh | New protein human MP52 Arg. |
DE19647853A1 (de) | 1996-11-19 | 1998-05-20 | Bioph Biotech Entw Pharm Gmbh | Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität |
EP1074620A1 (en) | 1999-08-06 | 2001-02-07 | HyGene AG | Monomeric protein of the TGF-beta family |
JPH11335398A (ja) | 1998-05-22 | 1999-12-07 | Hoechst Marion Roussel Kk | 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬 |
AU1024899A (en) | 1997-09-19 | 1999-04-12 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Cytokines having neurotrophic activity |
US6992066B2 (en) * | 1998-10-16 | 2006-01-31 | Zimmer Orthobiologics, Inc. | Povidone-containing carriers for polypeptide growth factors |
US7020845B1 (en) * | 1999-11-15 | 2006-03-28 | Gottfurcht Elliot A | Navigating internet content on a television using a simplified interface and a remote control |
US7479279B2 (en) | 2001-03-23 | 2009-01-20 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka | Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
EP1558444B1 (en) * | 2002-06-24 | 2016-09-21 | Tufts University | Silk biomaterials and methods of use thereof |
TW200410714A (en) | 2002-08-07 | 2004-07-01 | Smithkline Beecham Corp | Electrospun amorphous pharmaceutical compositions |
EP1462126A1 (en) | 2003-03-28 | 2004-09-29 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Improved Osteoinductive Materials |
JP2005005144A (ja) * | 2003-06-12 | 2005-01-06 | Nemoto:Kk | スイッチカバー |
US7704740B2 (en) * | 2003-11-05 | 2010-04-27 | Michigan State University | Nanofibrillar structure and applications including cell and tissue culture |
JP4618997B2 (ja) * | 2003-12-09 | 2011-01-26 | テルモ株式会社 | ステントおよびその製造方法 |
US8221780B2 (en) * | 2004-04-20 | 2012-07-17 | Depuy Mitek, Inc. | Nonwoven tissue scaffold |
EP1698691A1 (en) * | 2005-03-04 | 2006-09-06 | Biopharm Gesellschaft zur biotechnologischen Entwicklung von Pharmaka mbH | Growth factor mutants with improved biological activity |
JP2006254722A (ja) * | 2005-03-15 | 2006-09-28 | Toray Ind Inc | 細胞足場材料 |
DE102005048939A1 (de) | 2005-07-01 | 2007-01-11 | Carl Freudenberg Kg | Vorrichtung, Anordnung und Verfahren zur Herstellung von Fasern und eine solche Fasern umfassende Anordnung |
US20100303881A1 (en) * | 2006-02-02 | 2010-12-02 | The John Hopkins University | Therapeutic Electrospun Fiber Compositions |
EP1880731A1 (en) * | 2006-07-18 | 2008-01-23 | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH | Human growth and differentiation factor GDF-5 |
US8911996B2 (en) * | 2007-01-31 | 2014-12-16 | Technion Research & Development Foundation Limited | Electrospun scaffolds and methods of generating and using same |
DE102007011606A1 (de) * | 2007-03-02 | 2008-09-04 | Carl Freudenberg Kg | Faser-Wirrgelege |
MY154108A (en) | 2007-09-13 | 2015-04-30 | Dredging Int | A method and system for optimizing dredging |
DE102007044648B4 (de) | 2007-09-18 | 2020-11-26 | Carl Freudenberg Kg | Bioresorbierbarer Gelatinevliesstoff |
US20090163936A1 (en) | 2007-12-21 | 2009-06-25 | Chunlin Yang | Coated Tissue Engineering Scaffold |
US20100002151A1 (en) * | 2008-07-01 | 2010-01-07 | Yang Pan | Handheld media and communication device with a detachable projector |
US7644955B1 (en) * | 2008-07-03 | 2010-01-12 | Naris Komolrochanaporn | Quick coupling type fitting |
US8557271B2 (en) * | 2008-07-16 | 2013-10-15 | Warsaw Orthopedic, Inc. | Drug depot implantable within a joint |
TWM370392U (en) * | 2009-06-19 | 2009-12-11 | zhi-sheng Chen | Curative ventilating dressing |
US20130122066A1 (en) * | 2010-07-30 | 2013-05-16 | Biopham Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh | Drug delivery devices and growth factor formulations for accelerated wound healing |
EP2537538A1 (en) | 2011-06-22 | 2012-12-26 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH | Bioresorbable Wound Dressing |
-
2011
- 2011-06-22 EP EP11170971A patent/EP2537538A1/en not_active Ceased
-
2012
- 2012-06-21 KR KR1020147001041A patent/KR101964482B1/ko active IP Right Grant
- 2012-06-21 ES ES12729582.2T patent/ES2539405T3/es active Active
- 2012-06-21 CN CN201280037651.7A patent/CN103874516B/zh not_active Expired - Fee Related
- 2012-06-21 TW TW101122140A patent/TWI572336B/zh not_active IP Right Cessation
- 2012-06-21 JP JP2014516347A patent/JP6138773B2/ja not_active Expired - Fee Related
- 2012-06-21 US US14/128,185 patent/US9278156B2/en not_active Expired - Fee Related
- 2012-06-21 BR BR112013032714A patent/BR112013032714A2/pt not_active Application Discontinuation
- 2012-06-21 WO PCT/EP2012/061965 patent/WO2012175611A1/en active Application Filing
- 2012-06-21 AU AU2012274046A patent/AU2012274046C1/en not_active Ceased
- 2012-06-21 RU RU2014101762/15A patent/RU2577155C2/ru not_active IP Right Cessation
- 2012-06-21 EP EP12729582.2A patent/EP2723408B1/en not_active Not-in-force
- 2012-06-21 CA CA2839142A patent/CA2839142C/en not_active Expired - Fee Related
-
2013
- 2013-12-10 ZA ZA2013/09341A patent/ZA201309341B/en unknown
-
2016
- 2016-01-15 US US14/996,483 patent/US9782511B2/en not_active Expired - Fee Related
-
2017
- 2017-09-06 US US15/696,321 patent/US20180008743A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2012274046C1 (en) | 2016-07-14 |
US9782511B2 (en) | 2017-10-10 |
US20180008743A1 (en) | 2018-01-11 |
EP2723408B1 (en) | 2015-04-15 |
EP2537538A1 (en) | 2012-12-26 |
WO2012175611A1 (en) | 2012-12-27 |
CA2839142A1 (en) | 2012-12-27 |
TW201302170A (zh) | 2013-01-16 |
EP2723408A1 (en) | 2014-04-30 |
RU2014101762A (ru) | 2015-07-27 |
TWI572336B (zh) | 2017-03-01 |
CN103874516B (zh) | 2016-06-01 |
US20140141050A1 (en) | 2014-05-22 |
AU2012274046B2 (en) | 2016-02-18 |
US20160199530A1 (en) | 2016-07-14 |
RU2577155C2 (ru) | 2016-03-10 |
CA2839142C (en) | 2019-04-16 |
ZA201309341B (en) | 2015-11-25 |
CN103874516A (zh) | 2014-06-18 |
JP6138773B2 (ja) | 2017-05-31 |
AU2012274046A1 (en) | 2014-01-23 |
KR20140146035A (ko) | 2014-12-24 |
KR101964482B1 (ko) | 2019-04-01 |
JP2014522918A (ja) | 2014-09-08 |
US9278156B2 (en) | 2016-03-08 |
ES2539405T3 (es) | 2015-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013032714A2 (pt) | curativo para ferida biorreabsorvível | |
BRPI1012602A8 (pt) | Linha que possui estruturas revestidas para ancoragem para ancoragem em tecidos biológicos e sistema para fechamento de ferida e kit de peças cirúrgicas | |
BR112014008220A2 (pt) | dispositivos médicos que contêm composições de polímeros com memória de forma | |
BR112014007069A2 (pt) | proteínas de fusão para o tratamento de distúrbios metabólicos | |
CL2008002089A1 (es) | Compuesto para la regeneracion de tejidos que comprende al menos una sustancia derivada de sangre y acido hialuronico y/o al menos un compuesto derivado de acido hialuronico; metodo para la prepararcion de dicho compuesto. | |
NI201200171A (es) | Anticuerpos hacia gdf8 humano | |
CR20110526A (es) | Anticuerpos anti - tnf - alfa y sus usos | |
ECSP12011584A (es) | Anticuerpos anti-vegf y sus usos | |
EA201390739A1 (ru) | Способ лечения fgf21-ассоциированных расстройств | |
CU23880B1 (es) | Anticuerpos monoclonales contra el inhibidor de la vía del factor tisular (tfpi) | |
EP3747457A3 (en) | Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases | |
BRPI1011564A8 (pt) | Fio de material de sutura cirúrgica, kit cirúrgico e método para produzir fio | |
BRPI0920259A8 (pt) | Molécula de fator sanguíneo modificado, composição farmacêutica, e, métodos para preparar uma molécula de fator sanguíneo modificado e para tratar um indivíduo sofrendo de um distúrbio de coagulação sanguínea | |
CL2008003545A1 (es) | Compuestos derivados del acido [(imidazol-1-il)-1-hidroxi-1-fosfono-etil]-fosfonico; metodo de preparacion; composicion farmaceutica; y uso para el tratamiento de una resorcion osea excesiva o inapropiada o de una enfermedad causada por una prenilacion excesiva de proteinas objetivo. | |
BR112014003071A2 (pt) | tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical | |
BR102016007036A8 (pt) | material de reparo de tecido derivado de pele de peixe e método de fabricação do mesmo | |
ATE510536T1 (de) | Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen | |
BR112016003082A8 (pt) | uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida | |
BRPI0608277A2 (pt) | método e composição para o reparo de tecidos do coração | |
BR112013024951A2 (pt) | método de tratamento de tecidos biológicos, membranas ou outras estruturas, e, composição para a coloração de tecidos biológicos, membranas ou outras estruturas | |
BRPI0914454A2 (pt) | "composição para o tratamento do tecido epitelial" | |
BR112012013035A2 (pt) | fibronectina: quimeras do fator do crescimento | |
BRPI0917552B8 (pt) | kit para o tratamento de onicomicose | |
WO2014053906A8 (en) | The application of stem cells in the orthodontic maxillary expansion | |
BR112012030821A2 (pt) | vitronectina:fator de crescimento quimeras queratinócitos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |